hsa_circ_0001947 suppresses acute myeloid leukemia progression via targeting hsa-miR-329-5p/CREBRF axis

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Circular RNAs (circRNAs) are increasingly recognized for their roles in cancer biology.
• The specific involvement of circRNAs in acute myeloid leukemia (AML) pathogenesis is not well understood.

Purpose of the Study:

• To identify novel circRNAs implicated in the development and progression of AML.
• To elucidate the functional role of a specific circRNA, hsa_circ_0001947, in AML.

Main Methods:

• CircRNA microarray analysis to identify differentially expressed circRNAs.
• Quantitative reverse transcription PCR (qRT-PCR) for expression analysis of hsa_circ_0001947.
• siRNA-mediated knockdown to assess the in vitro and in vivo functions of hsa_circ_0001947.
• Dual-luciferase assays and mimics/inhibitors to determine target gene interactions.

Main Results:

• hsa_circ_0001947 was identified as a differentially expressed circRNA in AML.
• hsa_circ_0001947 functions as a tumor suppressor, inhibiting AML cell proliferation.
• This suppressive effect is mediated through the hsa-miR-329-5p/CREBRF axis.

Conclusions:

• hsa_circ_0001947 acts as a novel tumor inhibitor in acute myeloid leukemia.
• hsa_circ_0001947 holds potential as a therapeutic biomarker for AML treatment.